May 7, 2020 / 1:15 PM / a month ago

BRIEF-Sierra Oncology Reports Q1 Net Loss Per Share Of $3.14

May 7 (Reuters) - Sierra Oncology Inc:

* SIERRA ONCOLOGY REPORTS FIRST QUARTER 2020 RESULTS

* SIERRA ONCOLOGY INC - IMPACT OF COVID-19 UNCERTAIN BUT MAY POTENTIALLY AFFECT OVERALL MOMENTUM TIMELINES

* SIERRA ONCOLOGY INC - QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $3.14

* SIERRA ONCOLOGY - ANTICIPATES CURRENT RESOURCES SUFFICIENT TO EXECUTE DEVELOPMENT STRATEGY FOR MOMELOTINIB INTO H2 2022, SUBJECT TO POTENTIAL COVID-19 IMPACT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below